Showing 1,021 - 1,040 results of 8,196 for search '"Trial ', query time: 0.08s Refine Results
  1. 1021
  2. 1022
  3. 1023
  4. 1024
  5. 1025
  6. 1026
  7. 1027
  8. 1028

    No Difference between Spinal Anesthesia with Hyperbaric Ropivacaine and Intravenous Dexmedetomidine Sedation with and without Intrathecal Fentanyl: A Randomized Noninferiority Trial by Seung Cheol Lee, Tae Hyung Kim, So Ron Choi, Sang Yoong Park

    Published 2022-01-01
    “…To enhance the duration of single-shot spinal anesthesia, intrathecal fentanyl and intravenous dexmedetomidine are widely used as adjuvants to local anesthetics. This noninferiority trial evaluated whether hyperbaric ropivacaine alone can produce a noninferior duration of sensory block in comparison to hyperbaric ropivacaine with intrathecal fentanyl in patients under dexmedetomidine sedation. …”
    Get full text
    Article
  9. 1029
  10. 1030
  11. 1031

    A Reappraisal of Women’s Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50–59 Years of Age by Eric Roehm

    Published 2015-01-01
    “…The Women’s Health Initiative (WHI) Estrogen-Alone Trial randomized postmenopausal women, 50 to 79 years of age, with prior hysterectomy, to conjugated equine estrogens (CEE) or placebo with a 5.9-year median duration of CEE use. …”
    Get full text
    Article
  12. 1032

    Survival in patients with CKD 3–5 after 12 months of exercise training – a post-hoc analysis of the RENEXC trial by Sara Denguir, Matthias Hellberg, Martin Almquist, Naomi Clyne

    Published 2025-01-01
    “…These factors require elucidation in future studies. Trial registration ClinicalTrials.gov NCT02041156. …”
    Get full text
    Article
  13. 1033

    Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application by Kaichun Li, Jin Li

    Published 2016-01-01
    “…Unfortunately, none of the EGFR targeting antibodies (cetuximab or panitumumab), VEGF targeting monoclonal antibodies (bevacizumab), mTOR inhibitor (everolimus), or HGF/MET pathway targeting drugs has a significant survival benefit. Many other clinical trials based on molecular markers are underway. This review will summarize targeted therapies for advanced gastric cancer.…”
    Get full text
    Article
  14. 1034

    The Effects of Maternal Supplementation of Polyunsaturated Fatty Acids on Visual, Neurobehavioural, and Developmental Outcomes of the Child: A Systematic Review of the Randomized Trials by Andrea Lo, Julianna Sienna, Eva Mamak, Nada Djokanovic, Carol Westall, Gideon Koren

    Published 2012-01-01
    “…However, no systematic review of the randomized trials has been conducted. The objective of this review was to evaluate potential advantages of this regiment by reviewing all randomized trials in pregnancy. …”
    Get full text
    Article
  15. 1035
  16. 1036
  17. 1037
  18. 1038

    Effects of kinesio taping in patients undergoing knee or hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials by Ting Mei, Yuli Shuai, Dandong Wu, Heping Yu

    Published 2025-02-01
    “…Results: Eleven randomized controlled trials involving 774 participants met the inclusion criteria. …”
    Get full text
    Article
  19. 1039
  20. 1040

    Therapeutic effect and potential mechanism of Fufang Danshen dripping pills for stable coronary heart disease: a randomized controlled trial by Li-qin Meng, Li-qin Meng, Pei-ying Huang, Qing-min Li, Yu-chao Feng, Yu-chao Feng, Yu-chao Feng, Ding-jian Li, Guang-long Wu, Bo-wen Ao, Guo-chao Wu, Guo-xiong Zhang, Bo-jun Chen, Bo-jun Chen, Bo-jun Chen

    Published 2025-01-01
    “…This therapeutic effect is likely due to the active components of FFDS targeting key proteins: LPL, CD36, FABPpm, L-FABP, LCAT, and CEPT.Clinical Trial Registrationhttps://www.chictr.org.cn/, identifier (ChiCTR2400080149).…”
    Get full text
    Article